Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related CLDX
US Stock Futures Signal Higher Start On Wall Street
Celldex's Varlilumab Demonstrates Synergistic Anti-Tumor Activity with PD-1 Signaling Blockade in Preclinical Studies
Next Week In Biotech: Salix/Valeant PDUFA, ASCO, Brain Tumor Summit (Seeking Alpha)
Related BFAM
How To Profit From An Education Revolution
UPDATE: Bank Of America Reiterates On Bright Horizons Family Solutions On Strong Start To 2014
Hormel (HRL) Beats on Q2 Earnings, Falters on Revenues - Analyst Blog (Zacks)

Analysts at Leerink initiated coverage on shares of Celldex Therapeutics (NASDAQ: CLDX) with an “outperform” rating. The target price range for Celldex is set to $18. Celldex's shares closed at $10.71 yesterday.

Credit Suisse initiated coverage on shares of Bright Horizons Family Solutions LLC (NYSE: BFAM) with an “outperform” rating. The target price for Bright Horizons is set to $35. Bright Horizons' stock closed at $28.35 yesterday.

RBC Capital initiated coverage on shares of Walter Energy (NYSE: WLT) with a “sector perform” rating. The target price for Walter Energy is set to $34. Walter Energy's shares closed at $29.76 yesterday.

Analysts at Roth Capital initiated coverage on shares of Cytori Therapeutics (NASDAQ: CYTX) with a “buy” rating. The target price for Cytori Therapeutics is set to $8. Cytori Therapeutics' shares closed at $2.69 yesterday.

Latest Ratings for CLDX

DateFirmActionFromTo
Mar 2015JefferiesMaintainsBuy
Mar 2015Cantor FitzgeraldMaintainsBuy
Sep 2014Cowen & CompanyInitiates Coverage onOutperform

View More Analyst Ratings for CLDX
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (CLDX + BFAM)

Around the Web, We're Loving...